LORRAINE BYRD: Open Payments
NPI 1538316443 · RINCON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,360 in 143 payments from 25 companies in 2025. Trend: 2023 $2,199 · 2024 $2,695 · 2025 $3,360
Food & beverage: $3,326Education: $34
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 18 | $613 |
| GlaxoSmithKline, LLC. | 24 | $329 |
| Regeneron Healthcare Solutions, Inc. | 12 | $323 |
| Inspire Medical Systems, Inc. | 4 | $304 |
| Grifols USA, LLC | 9 | $247 |
| GENZYME CORPORATION | 8 | $209 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $170 |
| Verona Pharma, Inc. | 7 | $168 |
| Avadel CNS Pharmaceuticals, LLC | 12 | $166 |
| Amgen Inc. | 7 | $151 |
Products named: DUPIXENT, TEZSPIRE, INSPIRE, FASENRA, Prolastin-C Liquid, NUCALA, Ohtuvayre, LUMRYZ.
Industry payments across GA — which companies pay providers there.
